A phase II clinical trial of toripalimab in advanced solid tumors with polymerase epsilon/polymerase delta (POLE/POLD1) mutation.
Signal Transduct Target Ther
; 9(1): 227, 2024 Sep 02.
Article
in En
| MEDLINE
| ID: mdl-39218995
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
DNA Polymerase II
/
Antibodies, Monoclonal, Humanized
/
Mutation
/
Neoplasms
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Signal Transduct Target Ther
Year:
2024
Document type:
Article
Country of publication:
Reino Unido